INVESTORS / Shareholding
Information on the quarterly-wise shareholding pattern

FINANCIAL RESULTS FY2023-24

For more information write to investorrelations@lauruslabs.com

Find out more about us
Strengths & Strategy

We are building on our strengths to further extend our product portfolio and target fast-growing segments.
Research & Development

As a science-led pharmaceutical company, we invest in cutting-edge research to develop new cures for challenging diseases.

Corporate Sustainability

As a responsible corporate citizen, we will conduct our business with complete respect for the environment and community.